Doyle John Brendan (CIK 1840738) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-04). Recent activity: Sell CGTX (8,567 shares), Buy CGTX (10,000 shares), Sell CGTX (1,560 shares), Buy CGTX (200,000 shares), Sell CGTX (26,921 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-04 | COGNITION THERAPEUTICS INC (CGTX) | Chief Financial Officer | Sell | 8,567 | $10,966 |
| 2026-04-20 | COGNITION THERAPEUTICS INC (CGTX) | Chief Financial Officer | Buy | 10,000 | $11,300 |
| 2026-02-18 | COGNITION THERAPEUTICS INC (CGTX) | Chief Financial Officer | Sell | 1,560 | $1,747 |
| 2026-02-05 | COGNITION THERAPEUTICS INC (CGTX) | Chief Financial Officer | Buy | 200,000 | $0 |
| 2026-02-05 | COGNITION THERAPEUTICS INC (CGTX) | Chief Financial Officer | Sell | 26,921 | $27,729 |
| 2025-12-22 | COGNITION THERAPEUTICS INC (CGTX) | Chief Financial Officer | Buy | 30,000 | $0 |
| 2025-12-22 | COGNITION THERAPEUTICS INC (CGTX) | Chief Financial Officer | Sell | 9,360 | $14,040 |
| 2025-07-31 | COGNITION THERAPEUTICS INC (CGTX) | Chief Financial Officer | Buy | 30,000 | $0 |
| 2025-07-31 | COGNITION THERAPEUTICS INC (CGTX) | Chief Financial Officer | Sell | 9,360 | $6,271 |
| 2025-05-02 | COGNITION THERAPEUTICS INC (CGTX) | Chief Financial Officer | Sell | 9,692 | $4,361 |
Source: SEC Form 4 filings · as of 2026-05-04